NCT06394739 · Inari Medical
RevCore for In Stent Thrombosis
(REVIT)
What this study is about
The purpose of this research is to collect information about how the RevCore Thrombectomy Catheter works to treat stent blockages.
View original scientific description
The purpose of this research is to collect information about how the RevCore Thrombectomy Catheter works to treat stent blockages.
Who can participate
This study lists these criteria on ClinicalTrials.gov. A study coordinator reviews eligibility during screening — this page does not determine whether you qualify.
Inclusion criteria
- Age ≥ 18 years
- Patients with stent age \> 6 weeks
- Location of thrombosed stents in proximal lower extremity deep vein segments including at least common femoral, external iliac, or common iliac vein
- RevCore Thrombectomy Catheter must enter vasculature
- Willing and able to provide informed consent
Exclusion criteria
- Exposed stents with broken struts, significantly deformed struts, struts protruding into the vessel
- Stents not wall apposed
- Stents compressed to \<10mm
- Bilateral in-stent thrombosis
- Congenital anatomic anomalies of the iliac veins
- Allergy, hypersensitivity, or thrombocytopenia from heparin or iodinated contrast agents, except for mild to moderate contrast allergies for which pretreatment can be used
- Any contraindication to anticoagulants or antiplatelets that, in the opinion of the Investigator, cannot be medically managed throughout the study period
- Chronic non-ambulatory status
- Known hypercoagulable states (e.g. antiphospholipid syndrome) that, in the opinion of the Investigator, cannot be medically managed throughout the study period
- Inability to secure venous access
- Subject has any condition for which, in the opinion of the Investigator, participation would not be in the best interest of the subject
- Current participation in another investigational drug or device treatment study
Where
- New Haven, Connecticut
- Washington D.C., District of Columbia
- Boise, Idaho
- Baltimore, Maryland
- New York, New York
- Asheville, North Carolina
- Cleveland, Ohio
- Columbus, Ohio
- Philadelphia, Pennsylvania
- Pittsburgh, Pennsylvania
- Spartanburg, South Carolina
- El Paso, Texas
And 4 more locations — see the full list below.
Frequently asked questions
What is a clinical trial?
A clinical trial is a research study that tests new medical treatments, drugs, devices, or procedures to determine their safety and effectiveness. Trials are carefully designed and monitored to protect participants while advancing medical knowledge.
Is it safe to participate?
Clinical trials follow strict safety guidelines and ethical standards. Trials must be reviewed and approved, and participants are closely monitored by medical professionals throughout the study. You can withdraw at any time if you choose.
Will I be compensated?
Many clinical trials offer compensation for your time, travel expenses, and inconvenience. The specific compensation varies by study and will be discussed during the screening process. All study-related medical care is typically provided at no cost to participants.
Will I receive a placebo instead of treatment?
When effective treatment exists, participants typically receive either the standard treatment plus the study intervention, or the standard treatment plus placebo. You would not be denied effective care. Placebos are primarily used when no proven treatment is available, or in addition to standard care. Your trial consent form will clearly explain what treatments you may receive.
Can I leave a trial if I change my mind?
Absolutely. Participation in clinical trials is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty or loss of benefits to which you are otherwise entitled.
How long does a clinical trial last?
Trial duration varies widely depending on the study design and purpose. Some trials last just a few weeks, while others may continue for months or years. The study coordinator will provide specific timeline information during your screening call.
Data: ClinicalTrials.gov · synced Jul 8, 2026 · Source of record for eligibility and locations